Magellan Obtains FDA Approval for Point-Of-Care Lead Test

Email not displaying correctly?
View it in your browser.
G2 LogoLab and Pathology Insider Logo
 
July 28, 2015

Medicare and Medicaid Turn 50 Years Old This Week

By Kelly A. Briganti, Editorial Director, G2 Intelligence

This week, on July 30, Medicare and Medicaid celebrate a 50th birthday. On that date in 1965, President Lyndon B. Johnson signed legislation establishing those federal health insurance programs. The Centers for Medicare and Medicaid Services report that there are currently 55 million Americans benefitting from Medicare and that "in any given month" over 70 million benefit from…

Read more...


Incorporating HIE Data Into Care Cuts Use of Lab Tests

By Lori Solomon, Editor, Diagnostic Testing & Emerging Technologies

Leveraging clinical data from a health information exchange (HIE) can significantly reduce the number of duplicate laboratory tests and radiology assessments performed in the emergency room, according to a pilot study published online in the Journal of the American Medical Informatics Association. In this study, the use of scribes (clinical liaisons) ensured efficient flow of HIE data to the treating clinicians, but…

Read more...



Magellan Obtains FDA Approval for Point-Of-Care Lead Test

By Ron Shinkman, Editor, Laboratory Industry Report

Magellan Diagnostics has received 510(k) regulatory approval from the U.S. Food and Drug Administration to market a new point-of-care test that would be used to test lead levels in blood.
The test, known as LeadCare Plus, is a point-of-care version of a test the Massachusetts-based Magellan has marketed in other guises for the past…

Read more...


Follow on Twitter  Forward to Friend 

For questions concerning delivery of this email, please contact customer service at: (888) 729-2315 | customerservice@plainlanguagemedia.com

Copyright © 2015, All rights reserved.
Plain Language Media LLLP
PO Box 509
New London, CT
06320